1. "Journal for ImmunoTherapy of Cancer"
Formats
  1. Meeting Abstract (237)
  2. Journal Article (124)
  3. Guidelines (19)
  4. Review (5)
  5. Editorial (2)
  6. Correspondence (1)
Groups
  1. Department of Medicine (333)
  2. Solid Tumor Oncology Division (304)
  3. Melanoma and Immunotherapeutics Service (126)
  4. GSK Faculty (117)
  5. Hematologic Malignancies, Division of (91)
  6. Sloan Kettering Institute Postdocs (85)

More Groups

People
  1. Jedd Wolchok (81)
  2. Taha Merghoub (55)
  3. Michael Postow (33)
  4. Matthew Hellmann (30)
  5. Roberta Zappasodi (24)
  6. Sadna Budhu (22)

More People

Years
  1. 2024 (7)
  2. 2023 (21)
  3. 2022 (75)
  4. 2021 (57)
  5. 2020 (58)
  6. 2019 (34)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (388)
Publishers
  1. Biomed Central Ltd (388)

Results (388)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Suppressive effects of obesity on NK cells: Is it time to incorporate obesity as a clinical variable for NK cell-based cancer immunotherapy regimens?
    Editorial

    Canter, R. J.; Judge, S. J.; Collins, C. P.; Yoon, D. J.; Murphy, W. J.
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors
    Journal Article

    Khushalani, N. I.; Ott, P. A.; Ferris, R. L.; Cascone, T.; Schadendorf, D.; Le, D. T.; Sharma, M. R.; Barlesi, F.; Sharfman, W.; Luke, J. J.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy
    Guidelines

    Betof Warner, A.; Hamid, O.; Komanduri, K.; Amaria, R.; Butler, M. O.; Haanen, J.; Nikiforow, S.; Puzanov, I.; Sarnaik, A.; Bishop, M. R.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Phase 1/2 study of monalizumab plus durvalumab in patients with advanced solid tumors
    Journal Article

    Patel, S. P.; Alonso-Gordoa, T.; Banerjee, S.; Wang, D.; Naidoo, J.; Standifer, N. E.; Palmer, D. C.; Cheng, L. Y.; Kourtesis, P.; Ascierto, M. L.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pancreatic adenocarcinoma (CheckMate 032)
    Journal Article

    Callahan, M.; Amin, A.; Kaye, F. J.; Morse, M. A.; Taylor, M. H.; Peltola, K. J.; Sharma, P.; O'Reilly, E. M.; Meadows Shropshire, S.; O'Brien, S.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Response to Yu and Fuhler et al
    Correspondence

    Magahis, P. T.; Maron, S. B.; Faleck, D.; Laszkowska, M.
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: Results from Study 111/KEYNOTE-146
    Journal Article

    Makker, V.; Taylor, M. H.; Aghajanian, C.; Cohn, A. L.; Brose, M. S.; Simone, C. D.; Cao, Z. A.; Suttner, L.; Loboda, A.; Cristescu, R.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancer
    Journal Article

    Alessi, J. V.; Price, A.; Richards, A. L.; Ricciuti, B.; Wang, X.; Elkrief, A.; Pecci, F.; Di Federico, A.; Gandhi, M. M.; Lebow, E. S.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Impact of Helicobacter pylori infection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitors
    Journal Article

    Magahis, P. T.; Maron, S. B.; Cowzer, D.; King, S.; Schattner, M.; Janjigian, Y.; Faleck, D.; Laszkowska, M.
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0
    Guidelines

    Pavlick, A. C.; Ariyan, C. E.; Buchbinder, E. I.; Davar, D.; Gibney, G. T.; Hamid, O.; Hieken, T. J.; Izar, B.; Johnson, D. B.; Kulkarni, R. P.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save